- Home
- SLDP vs ADCT Comparison
SLDP vs ADCT Comparison
Compare SLDP & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDP
- ADCT
- Stock Information
- Founded
- SLDP 2011
- ADCT 2011
- Country
- SLDP United States
- ADCT Switzerland
- Employees
- SLDP N/A
- ADCT N/A
- Industry
- SLDP Electrical Products
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- SLDP Energy
- ADCT Health Care
- Exchange
- SLDP Nasdaq
- ADCT Nasdaq
- Market Cap
- SLDP 230.9M
- ADCT 224.3M
- IPO Year
- SLDP N/A
- ADCT 2020
- Fundamental
- Price
- SLDP $1.29
- ADCT $2.03
- Analyst Decision
- SLDP Buy
- ADCT Strong Buy
- Analyst Count
- SLDP 4
- ADCT 5
- Target Price
- SLDP $2.75
- ADCT $8.00
- AVG Volume (30 Days)
- SLDP 1.6M
- ADCT 1.6M
- Earning Date
- SLDP 11-07-2024
- ADCT 11-07-2024
- Dividend Yield
- SLDP N/A
- ADCT N/A
- EPS Growth
- SLDP N/A
- ADCT N/A
- EPS
- SLDP N/A
- ADCT N/A
- Revenue
- SLDP $18,026,000.00
- ADCT $70,717,000.00
- Revenue This Year
- SLDP $2.53
- ADCT $6.58
- Revenue Next Year
- SLDP $95.43
- ADCT $11.78
- P/E Ratio
- SLDP N/A
- ADCT N/A
- Revenue Growth
- SLDP N/A
- ADCT N/A
- 52 Week Low
- SLDP $1.00
- ADCT $1.18
- 52 Week High
- SLDP $2.35
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- SLDP 47.64
- ADCT 45.58
- Support Level
- SLDP $1.05
- ADCT $1.80
- Resistance Level
- SLDP $1.23
- ADCT $3.49
- Average True Range (ATR)
- SLDP 0.05
- ADCT 0.40
- MACD
- SLDP 0.00
- ADCT -0.02
- Stochastic Oscillator
- SLDP 33.33
- ADCT 21.01
About SLDP Solid Power Inc.
Solid Power Inc is engaged in developing all-solid-state battery cell technology to enable the next generation of batteries for the EV and other markets. The company's planned business model is to license its all-solid-state battery cell designs and manufacturing know-how to top tier battery manufacturers or automotive original equipment manufacturers and to sell its sulfide-based solid electrolyte for incorporation into all-solid-state battery cells.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.